ENDPOINTS

Corvus' Phase 1 atopic dermatitis data prompt stock rally

Corvus Pharmaceuticals reported new Phase 1 data in atopic dermatitis that sent its stock price {$CRVS} up by as much as 35% premarket Friday. The results come from three cohorts of ...

May 9, 2025 - 11:59
 0
Corvus' Phase 1 atopic dermatitis data prompt stock rally
Corvus Pharmaceuticals reported new Phase 1 data in atopic dermatitis that sent its stock price {$CRVS} up by as much as 35% premarket Friday. The results come from three cohorts of ...
Read More

Tags:

Previous Article

‘Alien: Rogue Incursion’ is Getting a Non-VR Version Later This Year

Next Article

Heads up: StackSocial just dropped a new Babbel offer

Related Posts

Merck KGaA to buy rare cancer biotech SpringWorks for $3.9B

Merck KGaA to buy rare cancer biotech SpringWorks for $...

Apr 28, 2025  0

AstraZeneca, Daiichi eye first-line breast cancer market after Enhertu's early Phase 3 win

AstraZeneca, Daiichi eye first-line breast cancer marke...

Apr 22, 2025  0

Noma Therapy raises $4M for virtual ketamine-assisted therapy

Noma Therapy raises $4M for virtual ketamine-assisted t...

Apr 30, 2025  0